Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial

Stroke - United States
doi 10.1161/strokeaha.109.557330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2009English

Cholesterol Lowering, Nutrition and Stroke Prevention

Canadian Journal of Neurological Sciences
MedicineNeurology
2012English

Stroke Prevention in Atrial Fibrillation Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Rationale, Design, and Baseline Features of a Randomized Controlled Trial to Assess the Effects of Statin for the Secondary Prevention of Stroke: The Japan Statin Treatment Against Recurrent Stroke (J-Stars)

International Journal of Stroke
Neurology
2013English

Cholesterol Lowering for the Prevention of Stroke

Practical Neurology
MedicineNeurology
2003English

Variations Between Countries in Outcome After Stroke in the International Stroke Trial (IST)

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2001English

Rising Statin Use and Effect on Ischemic Stroke Outcome

BMC Medicine
Medicine
2004English

Changes in Stroke Epidemiology, Prevention, and Treatment

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Nutrition & Stroke - Prevention and Treatment

Scandinavian Journal of Nutrition
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy